CareTrust REIT Acquires Two Care Homes in the United Kingdom
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--CareTrust REIT, Inc. (NYSE:CTRE) (“CareTrust” or the “Company”) announced…
Automobili Lamborghini and The Italian Sea Group present the new Tecnomar for Lamborghini 101FT motoryacht
The motoryacht expresses its Lamborghini essence through distinctive lines and bold aesthetics,…
Sweden, the world’s first travel destination on prescription
A new research-backed initiative sees physicians recommending trips to Sweden for the…
New mobile units to drive early breast cancer detection in Alberta
EDMONTON, Alberta, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Breast cancer screening is…
All-Scenario Grid Forming Technology, Accelerating Wind and Solar as Main Power
SHENZHEN, China, Sept. 18, 2025 /PRNewswire/ -- The 3rd International Digital Energy Expo…
Facilitating Cross-border Payments for Chinese and Cambodian Residents: UnionPay-powered Wallets Achieve Significant Transaction Growth in Cambodia
PHNOM PENH, Cambodia, Sept. 18, 2025 /PRNewswire/ -- Under the joint guidance of…
Event and sports programme decisions made for LA28 and Brisbane 2032
19 September 2025 - The International Olympic Committee (IOC) Executive Board (EB) has approved…
CisionOne Expands AI-Powered Platform with Enhanced Instant Insights and Social Intelligence
Innovative upgrades unify traditional, social and media release distribution—giving PR teams faster,…
Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being…